Locanabio Revenue and Competitors
Estimated Revenue & Valuation
- Locanabio's estimated annual revenue is currently $5.7M per year.
- Locanabio's estimated revenue per employee is $155,000
Employee Data
- Locanabio has 37 Employees.
- Locanabio grew their employee count by -57% last year.
Locanabio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Locanabio?
We are creating a new class of precision medicines to treat a range of human genetic diseases. Locana's RNA-targeting technology platform allows us to precisely address these mutations on the level of RNA. By targeting RNA, our approach avoids the risk of off-target effects in DNA and is suited to address many diseases linked to dysfunctional processing of RNA. The wide range of potential indications is supported by the modularity of our RNA-targeting gene therapies which are composed of interchangeable components that provide exquisite control of specificity and activity. We are working hard to realize the potential of RNA-targeting gene therapy to treat a range of devastating illnesses. With world leadership in RNA biology and RNA-mediated disease and a top tier Board of Directors and panel of Scientific Advisors, we are poised to develop the next generation of genomic medicines for functional correction of disease.
keywords:N/A
N/A
Total Funding
37
Number of Employees
$5.7M
Revenue (est)
-57%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Locanabio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Associate Director, Human Resources | Reveal Email/Phone |
2 | Chairman | Reveal Email/Phone |
3 | Director (former CEO) | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Sr. Development Associate II | Reveal Email/Phone |
6 | Sr. Research Associate | Reveal Email/Phone |
7 | Senior Research Associate I | Reveal Email/Phone |
8 | Associate Scientist | Reveal Email/Phone |
9 | Executive Director, CMC Analytical and Formulation Development | Reveal Email/Phone |
10 | Director, Gene Therapy Process Development | Reveal Email/Phone |
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.3M | 37 | 6% | N/A |
#2 | $3.9M | 37 | -36% | $141M |
#3 | $7.2M | 37 | -14% | N/A |
#4 | $4.3M | 37 | 23% | N/A |
#5 | $7.4M | 37 | 9% | N/A |